Furthermore, UTX overexpression in renal tubular and mesangial cells has been shown to improve early DKD lesions in animal models, indicating its potential as a therapeutic target for DKD (Chen et al., 2019). This evidence concerns the gene KDM6A and diabetic kidney disease.